INVO News and Press, INVO BioScience Inc. From 11/14/22

INVO Bioscience Reports Third Quarter 2022 Financial Results PR Newswire Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla. , Nov. 14, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a co...

INVO Bioscience to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022 PR Newswire Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla. , Nov. 10, 2022 /PRNewswi...

INVO Bioscience Highlights INVOcell Progress From the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo INVO Bioscience Highlights INVOcell Progress From the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo PR Newswire ...

INVOcell Review Published in Current Opinion in Obstetrics and Gynecology PR Newswire SARASOTA, Fla. , Oct. 21, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO) , a commercial-stage fertility company focused on expanding access to advance...

INVO Bioscience to Exhibit at the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo INVO Bioscience to Exhibit at the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo PR Newswire SARASOTA, Fla. and ANAHEIM, C...

Dr. Sue Ellen Carpenter of INVO Bioscience's Atlanta-based INVO Center - Bloom Fertility - Named Top Doctor by Castle Connolly PR Newswire SARASOTA, Fla. and ATLANTA , Sept. 22, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a commerci...

INVO Bioscience ( NASDAQ: INVO ) said that Advanced Reproductive Centre, Hospital Canselor Tuanku Muhriz (HCTM), based in Kuala Lumpur, Malaysia, is making its INVOcell medical device for intravaginal culture (IVC) procedures available to patients. ( INVO ) is tra...

INVOcell Launched in Malaysia by Advanced Reproductive Centre, Hospital Canselor Tuanku Muhriz PR Newswire SARASOTA, Fla. , Aug. 25, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO), a commercial-stage fertility company focused on expanding a...

INVO Bioscience, Inc. (INVO) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Robert Blum – Investor Relations Steve Shum – Chief Executive Officer Mike Campbell – Chief Operating Officer and Vice President of ...

INVO BioScience press release ( NASDAQ: INVO ): Q2 GAAP EPS of -$0.23 beats by $0.01 . Revenue of $0.14M (-33.3% Y/Y) misses by $0.19M . As of June 30, 2022, the Company had approximately $2.0 million in cash. For further details see: INVO BioScience ...